Navigation Links
deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Date:10/11/2007

powering prevention of common diseases, including deCODE T2(TM) in type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; and deCODE MI(TM) for heart attack. deCODE is delivering on the promise of the new genetics(SM). On the web at http://www.decode.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

Contact:

deCODE genetics

Berglind Olafsdottir Edward Farmer Joy Bessenger

+354 664 2393 +1 212 343 2819 +1 212 481 3891

bro@decode.is edward.farmer@decode.is ir@decode.is


'/>"/>
SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
5. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
10. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
11. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014   Unique Pizza and Subs ... Pink: UPZS), a Delaware Corporation, is pleased to ... Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that ... agreement, US-based Larasan will work with Unique to ... through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... Germany , July 30, 2014 /PRNewswire/ ... use and computer-assisted ("robotic") colonoscopy system, today announced the ... recognized medical device executive, as a new member of ... a highly respected global visionary in the medical device ... President and Chief Executive Officer at Given Imaging Ltd. ...
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... March 8, 2011 (RBC Life Sciences: OTC Bulletin Board: ... provider of proprietary nutritional supplements, wound care and pain management ... to $28.2 million for the year ended December 31, 2010, ... period during 2009. For 2010, the Company reported net earnings ...
... Genus Oncology, LLC, a clinical-stage company focused on commercializing novel ... Orphan Drug Designation from the FDA,s Office of Orphan Products ... the treatment of pancreatic cancer. Orphan Drug ... for a product that treats a rare disease or condition ...
Cached Medicine Technology:RBC Life Sciences Reports Sales and Earnings Growth in 2010 2RBC Life Sciences Reports Sales and Earnings Growth in 2010 3Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer 2
(Date:7/30/2014)... 2014 Within weeks freshman will begin to pour ... hopes this will be a time of growth and the start ... pause; it may not be as easy as it looks. Some ... switch their major at least once and many will switch two ... the costs are exacerbated when switching in the later years of ...
(Date:7/30/2014)... 2014 Throughout the month of August, ... oral cancer screenings. Using a new technological tool called ... the disease in its early stages. , Oral cancer ... sinuses, throat and other areas in and around the ... and Ends Results (SEER) program, 30 percent of oral ...
(Date:7/30/2014)... Cucamonga, CA (PRWEB) July 30, 2014 Serial ... learning how to make millions. However, like most people, in ... Determined to find a better way, Paul carefully studied ... wealth and those who do not. Based on the knowledge ... to not only improve his life and health, but also ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... with depression are more likely to develop dementia, but researchers ... relationship between the two. Specifically, they haven,t been able ... -- does depression help bring on dementia, or does dementia ... online July 30 in the journal Neurology sheds ...
(Date:7/30/2014)... Ann Arbor, MI (PRWEB) July 30, 2014 ... Madrid vs. Manchester United Tickets in Ann Arbor, MI on ... in the world of international football will be competing on American ... at “The Big House,” in Ann Arbor, Mich. The home of ... venue is one of the most prestigious in all of American ...
Breaking Medicine News(10 mins):Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 2Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 4
... Vancouver E-counselling can significantly lower blood pressure, improve ... Stroke Foundation researcher Dr. Robert Nolan. ... medical treatment for high blood pressure," Dr. Nolan told ... Heart and Stroke Foundation and the Canadian Cardiovascular Society. ...
... HealthDay Reporter , FRIDAY, Oct. 21 (HealthDay News) -- Brawls ... games, but are they as vicious as they look? A ... League games end in significant injury. The study ... it,s hard to get traction for a powerful punch on ...
... National Heart, Lung, and Blood Institute (NHLBI), part of ... of a three arm multi-center, clinical trial studying treatments ... safety concerns. The trial found that people with ... prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than ...
... FRIDAY, Oct. 21 (HealthDay News) -- Inflammation and enlargement ... caused by bacteria associated with stomach inflammation and ulcers, ... hyperplasia, causes upper airway obstruction and is associated with ... that adenoid hyperplasia may be caused by gastrointestinal reflux ...
... Ph.D., co-director of Integrative Mathematical Oncology (IMO) at Moffitt ... Vanderbilt University and Gustavo Ayala, M.D., at Baylor College ... from the National Institutes of Health to create new ... models have the potential to be useful prognostic tools, ...
... -- ,The way the human circadian clock sets itself may ... when they,re flying west to east compared to the other ... which regulates many body processes, has to make regular adjustments ... person is and does this by delaying or advancing its ...
Cached Medicine News:Health News:E-counselling shows dramatic results in lowering blood pressure 2Health News:E-counselling shows dramatic results in lowering blood pressure 3Health News:Hockey Fistfights Rarely Cause Injuries, Study Claims 2Health News:Hockey Fistfights Rarely Cause Injuries, Study Claims 3Health News:Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful 2Health News:Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful 3Health News:Researchers get $3 million National Institutes of Health grant for mathematical models of prostate cancer aggressiveness 2Health News:New Animal Study Might Explain Jet Lag Differences 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: